Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


7,694

Procedures

32

Market Approvals

64

Published Papers

47%

reduction in hospital stay20

38%

reduction in donor skin21

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds caused by burns.

55%

reduction in wound area in 4 weeks2

33%

pain reduction in one week7

ReGenerCell™ is a medical device that allows medical professionals to swiftly create a suspension of skin cells that can trigger healing in chronic wounds, such as venous leg ulcers and diabetic foot ulcers.

78%

re-pigmentation2

reduced

healing time, risk of infection and scarring4,6,7

ReNovaCell™ is a medical device that delivers a skin cell suspension for treating aesthetic applications: restoring pigmentation, and improving the appearance of scars, sun-damaged skin, wrinkles and lesions.

Twitter

follow

Wednesday, May 24th, 2017 at 8:00am
Using the #ReCell medical device to treat burns leads to a shorter length of stay in hospital #SprayOnSkin #AvitaMedical #MedTech https://t.co/9Yp5pVEQBv AvitaMedical photo
1
1
Wednesday, May 24th, 2017 at 1:00am
#ReCell : safely used in >7500 procedures globally, achieving closure with less donor skin, and improved functional + aesthetic outcomes https://t.co/wHIZ8kQwkA AvitaMedical photo
1
1
Tuesday, May 23rd, 2017 at 10:54am
Dr. Wood, Dr. Wolkerstorfer and leading Chinese surgeons present their experiences with ReCell to 150 derms. Hosted by Shenyang Hospital. https://t.co/cH006K2UUA AvitaMedical photo
Tuesday, May 23rd, 2017 at 9:01am
Avita's Board of Directors show confidence by taking payment in company shares

https://t.co/qB7BzglCbc

Facebook

follow

Avita Medical
Avita MedicalWednesday, May 24th, 2017 at 11:00am

Using the #ReCell medical device to treat burns leads to a shorter length of stay in hospital #SprayOnSkin #AvitaMedical #MedTech

Avita Medical
Avita MedicalWednesday, May 24th, 2017 at 4:00am

#ReCell : safely used in >7500 procedures globally, achieving closure with less donor skin, and improved functional + aesthetic outcomes

Share Price

Last Trade: 0.09 Last Trade: 1.4293
High: 0.09 High: 1.45
Low: 0.09 Low: 1.34
Close: 0.09 Close: 1.38
Volume: 700,906 Volume: 18055
Prices are delayed by 20 minutes